Galmed Unveils Pharmacodynamic Blood Markers For Aramchol

Benzinga · 04/15 12:32
  • Analysis of blood samples from patients treated with Aramchol in ARMOR (Ph3 MASH Study) provides new and important insights into the biochemical and physiological effects of the drug.
  • The pharmacodynamic signature associated with Aramchol treatment revealed a decrease in markers of chronic systemic inflammation, oxidative and cardiac stress, and atherosclerotic plaque pathogenesis.
    • Data also show a significant decrease in ANP (Atrial Natriuretic Peptide), a clinically validated marker for heart failure.